In conclusion, the imbalance of RAS in COVID-19 leads to cellular fibrosis through virus-mediated downregulation of ACE2 in favor of the pro-fibrotic ACE/Ang II/AT1R axis (Khazaal et al., 2022). The gene discussed is ACE; the disease is COVID-19.